The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders.
Brain health
Global burden of disease study
Global campaign against headache
Health promotion
Migraine
Tension-type headache
World Health Organization
Journal
The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562
Informations de publication
Date de publication:
04 Jan 2024
04 Jan 2024
Historique:
received:
10
11
2023
accepted:
01
12
2023
medline:
5
1
2024
pubmed:
5
1
2024
entrez:
4
1
2024
Statut:
epublish
Résumé
The World Health Organization (WHO) Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders was developed by WHO to address the worldwide challenges and gaps in provision of care and services for people with epilepsy and other neurological disorders and to ensure a comprehensive, coordinated response across sectors to the burden of neurologic diseases and to promote brain health across life-course. Headache disorders constitute the second most burdensome of all neurological diseases after stroke, but the first if young and midlife adults are taken into account. Despite the availability of a range of treatments, disability associated with headache disorders, and with migraine, remains very high. In addition, there are inequalities between high-income and low and middle income countries in access to medical care. In line with several brain health initiatives following the WHOiGAP resolution, herein we tailor the main pillars of the action plan to headache disorders: (1) raising policy prioritization and strengthen governance; (2) providing effective, timely and responsive diagnosis, treatment and care; (3) implementing strategies for promotion and prevention; (4) fostering research and innovation and strengthen information systems. Specific targets for future policy actions are proposed. The Global Action Plan triggered a revolution in neurology, not only by increasing public awareness of brain disorders and brain health but also by boosting the number of neurologists in training, raising research funding and making neurology a public health priority for policy makers. Reducing the burden of headache disorders will not only improve the quality of life and wellbeing of people with headache but also reduce the burden of neurological disorders increasing global brain health and, thus, global population health.
Identifiants
pubmed: 38178049
doi: 10.1186/s10194-023-01700-3
pii: 10.1186/s10194-023-01700-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
4Informations de copyright
© 2023. The Author(s).
Références
World Health Organization (2023) Intersectoral global action plan on Epilepsy and other neurological disorders 2022–2031. World Health Organization, Geneva
Steiner TJ, Birbeck GL, Jensen RH et al (2022) The global campaign turns 18: a brief review of its activities and achievements. J Headache Pain 23:49. https://doi.org/10.1186/s10194-022-01420-0
doi: 10.1186/s10194-022-01420-0
pubmed: 35448941
pmcid: 9022610
Steiner TJ, World Headache Alliance (2004) Lifting the burden: the global campaign against headache. Lancet Neurol 3:204–205. https://doi.org/10.1016/S1474-4422(04)00703-3
doi: 10.1016/S1474-4422(04)00703-3
pubmed: 15039030
Leonardi M, Raggi A (2019) A narrative review on the burden of migraine: when the burden is the impact on people’s life. J Headache Pain 20:41. https://doi.org/10.1186/s10194-019-0993-0
doi: 10.1186/s10194-019-0993-0
pubmed: 31023226
pmcid: 6734273
GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 Diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet 396:1204–1222
doi: 10.1016/S0140-6736(20)30925-9
Safiri S, Pourfathi H, Eagan A et al (2022) Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain 163:e293–e309. https://doi.org/10.1097/j.pain.0000000000002275
doi: 10.1097/j.pain.0000000000002275
pubmed: 34001771
Ashina M, Buse DC, Ashina H et al (2021) Migraine: integrated approaches to clinical management and emerging treatments. Lancet 397:1505–1518. https://doi.org/10.1016/S0140-6736(20)32342-4
doi: 10.1016/S0140-6736(20)32342-4
pubmed: 33773612
Robbins MS (2021) Diagnosis and management of Headache: a review. JAMA 325:1874–1885. https://doi.org/10.1001/jama.2021.1640
doi: 10.1001/jama.2021.1640
pubmed: 33974014
Ferrari MD, Goadsby PJ, Burstein R et al (2022) Migraine. Nat Rev Dis Primers 8:2. https://doi.org/10.1038/s41572-021-00328-4
doi: 10.1038/s41572-021-00328-4
pubmed: 35027572
Tepper SJ (2019) Acute Treatment of Migraine. Neurol Clin 37:727–742. https://doi.org/10.1016/j.ncl.2019.07.006
doi: 10.1016/j.ncl.2019.07.006
pubmed: 31563229
Ailani J (2021) Acute Migraine Treatment. Continuum (Minneap Minn) 27:597–612. https://doi.org/10.1212/CON.0000000000000956
doi: 10.1212/CON.0000000000000956
pubmed: 34048394
Burch R (2021) Preventive migraine treatment. Continuum (Minneap Minn) 27:613–632. https://doi.org/10.1212/CON.0000000000000957
doi: 10.1212/CON.0000000000000957
pubmed: 34048395
Grazzi L, Toppo C, D’Amico D et al (2021) Non-pharmacological approaches to Headaches: non-invasive neuromodulation, Nutraceuticals, and behavioral approaches. Int J Environ Res Public Health 18:1503. https://doi.org/10.3390/ijerph18041503
doi: 10.3390/ijerph18041503
pubmed: 33562487
pmcid: 7914516
Steiner TJ, Jensen R, Katsarava Z et al (2021) Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description. J Headache Pain 22:78. https://doi.org/10.1186/s10194-021-01265-z
doi: 10.1186/s10194-021-01265-z
pubmed: 34289806
pmcid: 8293530
Tinelli M, Leonardi M, Paemeleire K et al (2021) Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology. J Headache Pain 22:99. https://doi.org/10.1186/s10194-021-01310-x
doi: 10.1186/s10194-021-01310-x
pubmed: 34425753
pmcid: 8383423
Tinelli M, Leonardi M, Paemeleire K et al (2021) Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusions. J Headache Pain 22:90. https://doi.org/10.1186/s10194-021-01305-8
doi: 10.1186/s10194-021-01305-8
pubmed: 34380429
pmcid: 8359596
Martelletti P, Leonardi M, Ashina M et al (2023) Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030. J Headache Pain 24:140. https://doi.org/10.1186/s10194-023-01666-2
doi: 10.1186/s10194-023-01666-2
pubmed: 37884869
pmcid: 10604921
Owolabi MO, Leonardi M, Bassetti C et al (2023) Global synergistic actions to improve brain health for human development. Nat Rev Neurol 19:371–383. https://doi.org/10.1038/s41582-023-00808-z
doi: 10.1038/s41582-023-00808-z
pubmed: 37208496
pmcid: 10197060
World Health Organization (2001) International Classification of Functioning, disability and health. World Health Organization, Geneva
Caponnetto V, Deodato M, Robotti M et al (2021) Comorbidities of primary headache disorders: a literature review with meta-analysis. J Headache Pain 22:71. https://doi.org/10.1186/s10194-021-01281-z
doi: 10.1186/s10194-021-01281-z
pubmed: 34261435
pmcid: 8278743
Wijeratne T, Grisold W, Dodick D, Carroll W (2019) World Brain Day 2019: migraine, the painful truth. Lancet Neurol 18(10):914. https://doi.org/10.1016/S1474-4422(19)30281-9
doi: 10.1016/S1474-4422(19)30281-9
pubmed: 31345666
Wijeratne T, Dodick DW, Lewis SL, Guekht A, Pochigaeva K, Grisold W (2023) World Brain Day 2023 - Brain Health and disability: leave no one behind. J Neurol Sci 451:120720. https://doi.org/10.1016/j.jns.2023.120720
doi: 10.1016/j.jns.2023.120720
pubmed: 37421882
Linde M, Gustavsson A, Stovner LJ et al (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19:703–711. https://doi.org/10.1111/j.1468-1331.2011.03612.x
doi: 10.1111/j.1468-1331.2011.03612.x
pubmed: 22136117
Raggi A, Grazzi L, Guastafierro E et al (2022) Addressing the cost of chronic and episodic migraine and its main drivers: a short-term longitudinal analysis from a third-level Italian center. Neurol Sci 43:5717–5724. https://doi.org/10.1007/s10072-022-06164-y
doi: 10.1007/s10072-022-06164-y
pubmed: 35618934
Tobin J, Ford JH, Tockhorn-Heidenreich A et al (2022) Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trials. J Med Econ 25:630–639. https://doi.org/10.1080/13696998.2022.2071528
doi: 10.1080/13696998.2022.2071528
pubmed: 35510376
Bulsei J, Leplus A, Donnet A et al (2021) Occipital nerve stimulation for refractory chronic cluster headache: a cost-effectiveness study. Neuromodulation 24:1083–1092. https://doi.org/10.1111/ner.13394
doi: 10.1111/ner.13394
pubmed: 33886139
Amoozegar F, Khan Z, Oviedo-Ovando M, Sauriol S, Rochdi D (2022) The Burden of Illness of Migraine in Canada: New insights on Humanistic and Economic cost. Can J Neurol Sci 49:249–262. https://doi.org/10.1017/cjn.2021.75
doi: 10.1017/cjn.2021.75
pubmed: 33875042
Mahon R, Lang A, Vo P et al (2021) Cost-effectiveness of Erenumab for the Preventive Treatment of Migraine in patients with prior treatment failures in Sweden. Pharmacoeconomics 39:357–372. https://doi.org/10.1007/s40273-020-00996-2
doi: 10.1007/s40273-020-00996-2
pubmed: 33491167
Hansson-Hedblom A, Axelsson I, Jacobson L, Tedroff J, Borgström F (2020) Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway. J Headache Pain 21:99. https://doi.org/10.1186/s10194-020-01162-x
doi: 10.1186/s10194-020-01162-x
pubmed: 32787820
pmcid: 7424684
Irimia P, Santos-Lasaosa S, García Bujalance L, Ramos Pinazo L, Rubio-Rodríguez D, Rubio-Terrés C (2021) Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain. Expert Rev Pharmacoecon Outcomes Res 21:285–297. https://doi.org/10.1080/14737167.2020.1768850
doi: 10.1080/14737167.2020.1768850
pubmed: 32484365
Schoenbrunner AR, Khansa I, Janis JE (2020) Cost-effectiveness of Long-Term, targeted OnabotulinumtoxinA versus peripheral trigger site deactivation Surgery for the treatment of refractory migraine headaches. Plast Reconstr Surg 145:401e–406e. https://doi.org/10.1097/PRS.0000000000006480
doi: 10.1097/PRS.0000000000006480
pubmed: 31985655
Giannouchos TV, Mitsikostas DD, Ohsfeldt RL, Vozikis A, Koufopoulou P (2019) Cost-effectiveness analysis of Erenumab Versus OnabotulinumtoxinA for patients with chronic migraine Attacks in Greece. Clin Drug Investig 39(10):979–990. https://doi.org/10.1007/s40261-019-00827-z
doi: 10.1007/s40261-019-00827-z
pubmed: 31302899
Mortel D, Kawatu N, Steiner TJ, Saylor D (2022) Barriers to headache care in low- and middle-income countries. eNeurologicalSci 29:100427. https://doi.org/10.1016/j.ensci.2022.100427
doi: 10.1016/j.ensci.2022.100427
pubmed: 36212617
pmcid: 9539775
Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC (2013) Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features. Headache 53(1):81–92. https://doi.org/10.1111/j.1526-4610.2012.02265.x
doi: 10.1111/j.1526-4610.2012.02265.x
pubmed: 23078241
Viana M, Tassorelli C, Allena M, Nappi G, Sjaastad O, Antonaci F (2013) Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain 14:14. https://doi.org/10.1186/1129-2377-14-14
doi: 10.1186/1129-2377-14-14
pubmed: 23565739
pmcid: 3620440
Cortijo E, Guerrero AL, Herrero S et al (2012) Hemicrania continua in a headache clinic: referral source and diagnostic delay in a series of 22 patients. J Headache Pain 13:567–569. https://doi.org/10.1007/s10194-012-0471-4
doi: 10.1007/s10194-012-0471-4
pubmed: 22821619
pmcid: 3444545
Frederiksen HH, Lund NL, Barloese MC, Petersen AS, Jensen RH (2020) Diagnostic delay of cluster headache: a cohort study from the Danish cluster Headache Survey. Cephalalgia 40:49–56. https://doi.org/10.1177/0333102419863030
doi: 10.1177/0333102419863030
pubmed: 31291778
Kim BS, Chung PW, Kim BK et al (2022) Diagnostic Delay and its predictors in Cluster Headache. Front Neurol 13:827734. https://doi.org/10.3389/fneur.2022.827734
doi: 10.3389/fneur.2022.827734
pubmed: 35222255
pmcid: 8866826
Diamond ML (2002) The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine. Neurology 58:S3-9. https://doi.org/10.1212/wnl.58.9_suppl_6.s3
doi: 10.1212/wnl.58.9_suppl_6.s3
pubmed: 12011267
Cevoli S, D’Amico D, Martelletti P et al (2009) Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia 29:1285–1293. https://doi.org/10.1111/j.1468-2982.2009.01874.x
doi: 10.1111/j.1468-2982.2009.01874.x
pubmed: 19438916
Viana M, Khaliq F, Zecca C et al (2020) Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort. Eur J Neurol 27:536–541. https://doi.org/10.1111/ene.14098
doi: 10.1111/ene.14098
pubmed: 31574197
Arroyo-Quiroz C, Kurth T, Cantu-Brito C, Lopez-Ridaura R, Romieu I, Lajous M (2014) Lifetime prevalence and underdiagnosis of migraine in a population sample of Mexican women. Cephalalgia 34:1088–1092. https://doi.org/10.1177/0333102414529196
doi: 10.1177/0333102414529196
pubmed: 24711606
Adams AM, Buse DC, Leroux E (2023) Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) study: methods and multi-country baseline findings for diagnosis rates and care. Cephalalgia 43(6):3331024231180611. https://doi.org/10.1177/03331024231180611
doi: 10.1177/03331024231180611
pubmed: 37314231
O’Brien HL, Cohen JM (2015) Young adults with headaches: the transition from adolescents to adults. Headache 55:1404–1409. https://doi.org/10.1111/head.12706
doi: 10.1111/head.12706
pubmed: 26518150
Antonaci F, Voiticovschi-Iosob C, Di Stefano AL, Galli F, Ozge A, Balottin U (2014) The evolution of headache from childhood to adulthood: a review of the literature. J Headache Pain 15:15. https://doi.org/10.1186/1129-2377-15-15
doi: 10.1186/1129-2377-15-15
pubmed: 24641507
pmcid: 3995299
VanderPluym JH, Charleston L 4th, Stitzer ME, Flippen CC 2, Armand CE, Kiarashi J (2022) A review of Underserved and vulnerable populations in Headache Medicine in the United States: challenges and opportunities. Curr Pain Headache Rep 26:415–422. https://doi.org/10.1007/s11916-022-01042-w
doi: 10.1007/s11916-022-01042-w
pubmed: 35347652
Bigal ME, Arruda MA (2010) Migraine in the pediatric population–evolving concepts. Headache 50:1130–1143. https://doi.org/10.1111/j.1526-4610.2010.01717.x
doi: 10.1111/j.1526-4610.2010.01717.x
pubmed: 20572878
Negro A, Delaruelle Z, Ivanova TA et al (2017) Headache and pregnancy: a systematic review. J Headache Pain 18:106. https://doi.org/10.1186/s10194-017-0816-0
doi: 10.1186/s10194-017-0816-0
pubmed: 29052046
pmcid: 5648730
Burch R (2019) Headache in pregnancy and the Puerperium. Neurol Clin 37:31–51. https://doi.org/10.1016/j.ncl.2018.09.004
doi: 10.1016/j.ncl.2018.09.004
pubmed: 30470274
Pareyson D, Pantaleoni C, Eleopra R et al (2021) Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy. Neurol Sci 42:2637–2644. https://doi.org/10.1007/s10072-021-05252-9
doi: 10.1007/s10072-021-05252-9
pubmed: 33929645
pmcid: 8086222
Grazzi L, Rizzoli P, Raggi A (2023) How the COVID-19 emergency changed our modality to treat patients with migraine: a positive aspect of the pandemic. Neurol Sci 44:809–810. https://doi.org/10.1007/s10072-022-06585-9
doi: 10.1007/s10072-022-06585-9
pubmed: 36576646
van de Graaf DL, Schoonman GG, Habibović M, Pauws SC (2021) Towards eHealth to support the health journey of headache patients: a scoping review. J Neurol 268:3646–3665. https://doi.org/10.1007/s00415-020-09981-3
doi: 10.1007/s00415-020-09981-3
pubmed: 32529582
Noutsios CD, Boisvert-Plante V, Perez J, Hudon J, Ingelmo P (2021) Telemedicine applications for the evaluation of patients with Non-acute Headache: a narrative review. J Pain Res 14:1533–1542. https://doi.org/10.2147/JPR.S309542
doi: 10.2147/JPR.S309542
pubmed: 34103978
pmcid: 8179807
Bentivegna E, Tassorelli C, De Icco R, Sances G, Martelletti P (2022) Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes. Expert Rev Neurother 22:237–243. https://doi.org/10.1080/14737175.2022.2045954
doi: 10.1080/14737175.2022.2045954
pubmed: 35196206
Spina E, Tedeschi G, Russo A et al (2022) Telemedicine application to headache: a critical review. Neurol Sci 43:3795–3801. https://doi.org/10.1007/s10072-022-05910-6
doi: 10.1007/s10072-022-05910-6
pubmed: 35075575
pmcid: 8786371
Lipton RB, Sico J, Seng EK (2023) Migraine screening in English and Spanish. Headache 63(7):843–845. https://doi.org/10.1111/head.14520
doi: 10.1111/head.14520
pubmed: 37140197
Lipton RB, Dodick D, Sadovsky R et al (2003) A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology 61(3):375–382. https://doi.org/10.1212/01.wnl.0000078940.53438.83
doi: 10.1212/01.wnl.0000078940.53438.83
pubmed: 12913201
Bigio J, MacLean E, Vasquez NA et al (2022) Most common reasons for primary care visits in low- and middle-income countries: a systematic review. PLOS Glob Public Health 2(5):e0000196. https://doi.org/10.1371/journal.pgph.0000196
doi: 10.1371/journal.pgph.0000196
pubmed: 36962326
pmcid: 10022248
Finley CR, Chan DS, Garrison S et al (2018) What are the most common conditions in primary care? Systematic review. Can Fam Physician 64(11):832–840
pubmed: 30429181
pmcid: 6234945
Evlice A, Genç H, Uluduz D et al (2023) Secondary headache disorders in Turkey, the Middle East, Asia, and Africa: a cross-sectional, multicenter study. Cephalalgia 43(8):3331024231194024. https://doi.org/10.1177/03331024231194024
doi: 10.1177/03331024231194024
pubmed: 37592903
Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 38:1-211. https://doi.org/10.1177/0333102417738202
Burch R (2019) Migraine and tension-type headache: diagnosis and treatment. Med Clin North Am 103:215–233. https://doi.org/10.1016/j.mcna.2018.10.003
doi: 10.1016/j.mcna.2018.10.003
pubmed: 30704678
Eigenbrodt AK, Ashina H, Khan S et al (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17:501–514. https://doi.org/10.1038/s41582-021-00509-5
doi: 10.1038/s41582-021-00509-5
pubmed: 34145431
pmcid: 8321897
Suri H, Ailani J (2021) Cluster headache: a review and update in treatment. Curr Neurol Neurosci Rep 21:31. https://doi.org/10.1007/s11910-021-01114-1
doi: 10.1007/s11910-021-01114-1
pubmed: 33948734
Evers S, Summ O (2021) Neurostimulation Treatment in Chronic Cluster Headache-a narrative review. Curr Pain Headache Rep 25:81. https://doi.org/10.1007/s11916-021-00989-6
doi: 10.1007/s11916-021-00989-6
pubmed: 34894300
pmcid: 8665918
Franzini A, Clerici E, Navarria P, Picozzi P (2022) Gamma Knife radiosurgery for the treatment of cluster headache: a systematic review. Neurosurg Rev 45:1923–1931. https://doi.org/10.1007/s10143-021-01725-9
doi: 10.1007/s10143-021-01725-9
pubmed: 35112222
Robbins MS, Robertson CE, Ailani J, Levin M, Friedman DI, Dodick DW (2016) Procedural Headache Medicine in Neurology Residency Training: a Survey of US Program directors. Headache 56:79–85. https://doi.org/10.1111/head.12695
doi: 10.1111/head.12695
pubmed: 26352267
Minen M, Shome A, Halpern A et al (2016) A migraine management training program for primary care providers: an overview of a survey and pilot study findings, lessons learned, and considerations for further research. Headache 56:725–740. https://doi.org/10.1111/head.12803
doi: 10.1111/head.12803
pubmed: 27037903
pmcid: 4890700
Ahmed ZA, Faulkner LR (2016) Headache Education in Adult Neurology Residency: a Survey of Program directors and Chief residents. Headache 56:871–877. https://doi.org/10.1111/head.12822
doi: 10.1111/head.12822
pubmed: 27040043
Ong JJY, Chan YC (2017) Medical undergraduate survey on Headache Education in Singapore: knowledge, perceptions, and Assessment of Unmet needs. Headache 57:967–978. https://doi.org/10.1111/head.13110
doi: 10.1111/head.13110
pubmed: 28488294
Raieli V, Loiacono C, Messina LM, Correnti E, Brighina F (2018) Is a digital platform useful in headache training? A 4-year Italian experience. Neurol Sci 39:2223–2224. https://doi.org/10.1007/s10072-018-3540-x
doi: 10.1007/s10072-018-3540-x
pubmed: 30121838
Pace A, Orr SL, Rosen NL, Safdieh JE, Cruz GB, Sprouse-Blum AS (2021) The current state of headache medicine education in the United States and Canada: an observational, survey-based study of neurology clerkship directors and curriculum deans. Headache 61:854–862. https://doi.org/10.1111/head.14134
doi: 10.1111/head.14134
pubmed: 34184273
Do TP, Dømgaard M, Stefansen S, Kristoffersen ES, Ashina M, Hansen JM (2022) Barriers and gaps in headache education: a national cross-sectional survey of neurology residents in Denmark. BMC Med Educ 22:233. https://doi.org/10.1186/s12909-022-03299-6
doi: 10.1186/s12909-022-03299-6
pubmed: 35365132
pmcid: 8976293
Marzouk M, Seng EK (2021) The impact of parental migraine on children. Curr Pain Headache Rep 24:81. https://doi.org/10.1007/s11916-020-00915-2
doi: 10.1007/s11916-020-00915-2
pubmed: 33409807
Lipton RB, Buse DC, Adams AM, Varon SF, Fanning KM, Reed ML (2017) Family Impact of Migraine: development of the impact of Migraine on partners and adolescent children (IMPAC) scale. Headache 57:570–585. https://doi.org/10.1111/head.13028
doi: 10.1111/head.13028
pubmed: 28185239
pmcid: 5396278
Buse DC, Scher AI, Dodick DW et al (2016) Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study. Mayo Clin Proc 91:596–611. https://doi.org/10.1016/j.mayocp.2016.02.013
doi: 10.1016/j.mayocp.2016.02.013
Arruda MA, Bigal ME (2012) Migraine and behavior in children: influence of maternal headache frequency. J Headache Pain 13:395–400. https://doi.org/10.1007/s10194-012-0441-x
doi: 10.1007/s10194-012-0441-x
pubmed: 22460944
pmcid: 3381068
Pohl H, Gantenbein AR, Sandor PS, Schoenen J, Andrée C (2020) Interictal burden of Cluster Headache: results of the EUROLIGHT Cluster Headache Project, an Internet-Based, cross-sectional study of people with cluster headache. Headache 60:360–369. https://doi.org/10.1111/head.13711
doi: 10.1111/head.13711
pubmed: 31762031
Buse DC, Fanning KM, Reed ML et al (2019) Life with Migraine: effects on relationships, Career, and Finances from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache 59:1286–1299. https://doi.org/10.1111/head.13613
doi: 10.1111/head.13613
pubmed: 31407321
pmcid: 6771487
Buse DC, Powers SW, Gelfand AA et al (2018) Adolescent perspectives on the Burden of a parent’s migraine: results from the CaMEO study. Headache 58:512–524. https://doi.org/10.1111/head.13254
doi: 10.1111/head.13254
pubmed: 29355924
Seng EK, Mauser ED, Marzouk M, Patel ZS, Rosen N, Buse DC (2019) When Mom has Migraine: an observational study of the impact of parental migraine on adolescent children. Headache 59:224–234. https://doi.org/10.1111/head.13433
doi: 10.1111/head.13433
pubmed: 30378682
Natalucci G, Faedda N, Baglioni V, Guidetti V (2020) The relationship between parental Care and Pain in Children with Headache: a narrative review. Headache 60:1217–1224. https://doi.org/10.1111/head.13822
doi: 10.1111/head.13822
pubmed: 32474926
May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12:455–464. https://doi.org/10.1038/nrneurol.2016.93
doi: 10.1038/nrneurol.2016.93
pubmed: 27389092
Diener HC, Holle D, Solbach K, Gaul C (2016) Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol 12:575–583. https://doi.org/10.1038/nrneurol.2016.124
doi: 10.1038/nrneurol.2016.124
pubmed: 27615418
Cho SJ, Chu MK (2015) Risk factors of chronic daily headache or chronic migraine. Curr Pain Headache Rep 19:465. https://doi.org/10.1007/s11916-014-0465-9
doi: 10.1007/s11916-014-0465-9
pubmed: 25416458
Schramm S, Tenhagen I, Schmidt B et al (2021) Prevalence and risk factors of migraine and non-migraine headache in older people - results of the Heinz Nixdorf Recall study. Cephalalgia 41:649–664. https://doi.org/10.1177/0333102420977183
doi: 10.1177/0333102420977183
pubmed: 33269953
Fagernæs CF, Heuch I, Zwart JA, Winsvold BS, Linde M, Hagen K (2015) Blood pressure as a risk factor for headache and migraine: a prospective population-based study. Eur J Neurol 22(156–62):e10-11. https://doi.org/10.1111/ene.12547
doi: 10.1111/ene.12547
Elbadawi ASA, Albalawi AFA, Alghannami AK et al (2021) Cluster headache and Associated Risk factors: a systemic review and Meta-analysis. Cureus 13:e19294. https://doi.org/10.7759/cureus.19294
doi: 10.7759/cureus.19294
pubmed: 34877226
pmcid: 8645418
Xie W, Li R, He M et al (2020) Prevalence and risk factors associated with headache amongst medical staff in South China. J Headache Pain 21:5. https://doi.org/10.1186/s10194-020-1075-z
doi: 10.1186/s10194-020-1075-z
pubmed: 31937239
pmcid: 6961346
D’Amico D, Sansone E, Grazzi L et al (2018) Multimorbidity in patients with chronic migraine and medication overuse headache. Acta Neurol Scand 138:515–522. https://doi.org/10.1111/ane.13014
doi: 10.1111/ane.13014
pubmed: 30107027
Kuo FH, Lee CY, Li JP et al (2020) Migraine as a risk factor for peripheral artery occlusive Disease: a Population-based Cohort Study. Int J Environ Res Public Health 17:8549. https://doi.org/10.3390/ijerph17228549
doi: 10.3390/ijerph17228549
pubmed: 33218041
pmcid: 7698948
Gelfand AA, Fullerton HJ, Jacobson A et al (2015) Is migraine a risk factor for pediatric Stroke? Cephalalgia 35:1252–1260. https://doi.org/10.1177/0333102415576222
doi: 10.1177/0333102415576222
pubmed: 25754176
pmcid: 4564362
Hassan M, Belavadi R, Gudigopuram SVR et al (2021) Migraine and Stroke: in search of Shared pathways, mechanisms, and risk factors. Cureus 13:e20202. https://doi.org/10.7759/cureus.20202
doi: 10.7759/cureus.20202
pubmed: 34900505
pmcid: 8647778
Norton J, Portet F, Gabelle A et al (2016) Are migraine and non-migrainous headache risk factors for Stroke in the elderly? Findings from a 12-year cohort follow-up. Eur J Neurol 23:1463–1470. https://doi.org/10.1111/ene.13060
doi: 10.1111/ene.13060
pubmed: 27399611
pmcid: 5517624
Tekgol Uzuner G, Yalın OO, Uluduz D, Ozge A, Uzuner N (2021) Migraine and cardiovascular risk factors: a clinic-based study. Clin Neurol Neurosurg 200:106375. https://doi.org/10.1016/j.clineuro.2020.106375
doi: 10.1016/j.clineuro.2020.106375
pubmed: 33260087
Elgendy IY, Nadeau SE, Bairey Merz CN et al (2019) Migraine Headache: an under-appreciated risk factor for Cardiovascular Disease in Women. J Am Heart Assoc 8:e014546. https://doi.org/10.1161/JAHA.119.014546
doi: 10.1161/JAHA.119.014546
pubmed: 31707945
pmcid: 6915301
Kurth T, Rist PM, Ridker PM, Kotler G, Bubes V, Buring JE (2020) Association of Migraine with Aura and other risk factors with Incident Cardiovascular Disease in Women. JAMA 323:2281–2289. https://doi.org/10.1001/jama.2020.7172
doi: 10.1001/jama.2020.7172
pubmed: 32515815
pmcid: 7284297
Klein A, Schankin CJ (2021) Visual snow syndrome, the spectrum of perceptual disorders, and migraine as a common risk factor: a narrative review. Headache 61:1306–1313. https://doi.org/10.1111/head.14213
doi: 10.1111/head.14213
pubmed: 34570907
pmcid: 9293285
Welander NZ, Mwinyi J, Asif S, Schiöth HB, Skalkidou A, Fransson E (2021) Migraine as a risk factor for mixed symptoms of peripartum depression and anxiety in late pregnancy: a prospective cohort study. J Affect Disord 295:733–739. https://doi.org/10.1016/j.jad.2021.08.119
doi: 10.1016/j.jad.2021.08.119
pubmed: 34517247
Guido D, Leonardi M, Mellor-Marsá B et al (2020) Pain rates in general population for the period 1991–2015 and 10-years prediction: results from a multi-continent age-period-cohort analysis. J Headache Pain 21:52. https://doi.org/10.1186/s10194-020-01108-3
doi: 10.1186/s10194-020-01108-3
pubmed: 32404046
pmcid: 7218619
Raggi A, Leonardi M, Mellor-Marsá B et al (2020) Predictors of pain in general ageing populations: results from a multi-country analysis based on ATHLOS harmonized database. J Headache Pain 21:45. https://doi.org/10.1186/s10194-020-01116-3
doi: 10.1186/s10194-020-01116-3
pubmed: 32375641
pmcid: 7201730
Sanchez-Niubo A, Forero CG, Wu YT et al (2021) Development of a common scale for measuring healthy ageing across the world: results from the ATHLOS consortium. Int J Epidemiol 50:880–892. https://doi.org/10.1093/ije/dyaa236
doi: 10.1093/ije/dyaa236
pubmed: 33274372
Grazzi L, D’Amico D, Guastafierro E et al (2023) Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study). J Headache Pain 24:86. https://doi.org/10.1186/s10194-023-01630-0
doi: 10.1186/s10194-023-01630-0
pubmed: 37452281
pmcid: 10347788
D’Amico D, Grazzi L, Guastafierro E, Sansone E, Leonardi M, Raggi A (2021) Withdrawal failure in patients with chronic migraine and medication overuse headache. Acta Neurol Scand 144:408–417. https://doi.org/10.1111/ane.13475
doi: 10.1111/ane.13475
pubmed: 34036572
pmcid: 8453823
GBD 2016 Meningitis Collaborators (2018) Global, regional, and national burden of Meningitis, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol 17:1061–1082. https://doi.org/10.1016/S1474-4422(18)30387-9
doi: 10.1016/S1474-4422(18)30387-9
GBD 2016 Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol 18:459–480. https://doi.org/10.1016/S1474-4422(18)30499-X
doi: 10.1016/S1474-4422(18)30499-X
Raggi A, Leonardi M (2020) Burden of brain disorders in Europe in 2017 and comparison with other non-communicable Disease groups. J Neurol Neurosurg Psychiatry 91:104–105. https://doi.org/10.1136/jnnp-2019-320466
doi: 10.1136/jnnp-2019-320466
pubmed: 31208991
Raggi A, Monasta L, Beghi E et al (2022) Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the global burden of Disease Study 2019. J Neurol 269:2080–2098. https://doi.org/10.1007/s00415-021-10774-5
doi: 10.1007/s00415-021-10774-5
pubmed: 34498172
Fernández-de-Las-Peñas C, Navarro-Santana M, Gómez-Mayordomo V et al (2021) Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur J Neurol 28:3820–3825. https://doi.org/10.1111/ene.15040
doi: 10.1111/ene.15040
pubmed: 34327787
pmcid: 8444899
Castaldo M, Waliszewska-Prosół M, Koutsokera M et al (2022) Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. J Headache Pain 23:41. https://doi.org/10.1186/s10194-022-01400-4
doi: 10.1186/s10194-022-01400-4
pubmed: 35361131
pmcid: 8969402
Tana C, Giamberardino MA, Martelletti P (2023) Long COVID and especially headache syndromes. Curr Opin Neurol 36(3):168–174. https://doi.org/10.1097/WCO.0000000000001153
doi: 10.1097/WCO.0000000000001153
pubmed: 37078648
Martelletti P, Bentivegna E, Spuntarelli V, Luciani M (2021) Long-COVID headache. SN Compr Clin Med 3:1704–1706. https://doi.org/10.1007/s42399-021-00964-7
doi: 10.1007/s42399-021-00964-7
pubmed: 34036244
pmcid: 8136258
Voormolen DC, Haagsma JA, Polinder S et al (2019) Post-concussion symptoms in complicated vs. Uncomplicated Mild Traumatic Brain Injury Patients at Three and Six Months Post-Injury: Results from the CENTER-TBI Study. J Clin Med Res 8:1921. https://doi.org/10.3390/jcm8111921
doi: 10.3390/jcm8111921
Aaseth K, Grande RB, Kvárner KJ, Gulbrandsen P, Lundqvist C, Russell MB (2008) Prevalence of secondary chronic headaches in a Population-based sample of 30-44-year-old persons. The Akershus Study of Chronic Headache. Cephalalgia 28:705–713. https://doi.org/10.1111/j.1468-2982.2008.01577.x
doi: 10.1111/j.1468-2982.2008.01577.x
pubmed: 18498398
Rasmussen BK, Olesen J (1992) Symptomatic and nonsymptomatic headaches in a general population. Neurology 42:1225–1231. https://doi.org/10.1212/wnl.42.6.1225
doi: 10.1212/wnl.42.6.1225
pubmed: 1603351
Benemei S, Labastida-Ramírez A, Abramova E et al (2020) Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence. J Headache Pain 21:90. https://doi.org/10.1186/s10194-020-01135-0
doi: 10.1186/s10194-020-01135-0
pubmed: 32664898
pmcid: 7362418
Taylor FR (2015) Tobacco, Nicotine, and Headache. Headache 55:1028–1044. https://doi.org/10.1111/head.12620
doi: 10.1111/head.12620
pubmed: 26140522
Rozen TD (2018) Cluster headache clinical phenotypes: Tobacco Nonexposed (never smoker and no parental secondary smoke exposure as a child) versus Tobacco-Exposed: results from the United States Cluster Headache Survey. Headache 58:688–699. https://doi.org/10.1111/head.13295
doi: 10.1111/head.13295
pubmed: 29536529
Friedman DI, De ver Dye T (2009) Migraine and the environment. Headache. 49:941 – 52. https://doi.org/10.1111/j.1526-4610.2009.01443.x
Martinelli D, Pocora MM, De Icco R, Putortì A, Tassorelli C (2022) Triggers of migraine: where do we stand? Curr Opin Neurol 35:360–366. https://doi.org/10.1097/WCO.0000000000001065
doi: 10.1097/WCO.0000000000001065
pubmed: 35674080
Shimizu T, Sakai F, Miyake H et al (2021) Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain 22:29. https://doi.org/10.1186/s10194-021-01243-5
doi: 10.1186/s10194-021-01243-5
pubmed: 33882816
pmcid: 8061063
Raggi A, Leonardi M, Sansone E, Curone M, Grazzi L, D’Amico D (2020) The cost and the value of treatment of medication overuse headache in Italy: a longitudinal study based on patient-derived data. Eur J Neurol 27:62–e1. https://doi.org/10.1111/ene.14034
de Begasse O, Sakai F (2022) Migraine in the workplace. eNeurologicalSci 27:100408. https://doi.org/10.1016/j.ensci.2022.100408
doi: 10.1016/j.ensci.2022.100408
Tietjen GE, Karmakar M, Amialchuk AA (2017) Emotional abuse history and migraine among young adults: a retrospective cross-sectional analysis of the add Health dataset. Headache 57:45–59. https://doi.org/10.1111/head.12994
doi: 10.1111/head.12994
pubmed: 27917478
Tietjen GE, Brandes JL, Peterlin BL et al (2010) Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for headache chronification. Headache 50:32–41. https://doi.org/10.1111/j.1526-4610.2009.01557.x
doi: 10.1111/j.1526-4610.2009.01557.x
pubmed: 19845781
Tietjen GE, Buse DC, Fanning KM, Serrano D, Reed ML, Lipton RB (2015) Recalled maltreatment, migraine, and tension-type headache: results of the AMPP study. Neurology 84:132–140. https://doi.org/10.1212/WNL.0000000000001120
doi: 10.1212/WNL.0000000000001120
pubmed: 25540306
pmcid: 4336089
Juang KD, Wang SJ, Fuh JL, Lu SR, Chen YS (2004) Association between adolescent chronic daily headache and childhood adversity: a community-based study. Cephalalgia 24(1):54–59. https://doi.org/10.1111/j.1468-2982.2004.00643.x
doi: 10.1111/j.1468-2982.2004.00643.x
pubmed: 14687014
Işik U, Topuzoğlu A, Ay P et al (2009) The prevalence of headache and its association with socioeconomic status among schoolchildren in Istanbul. Turk Headache 49:697–703. https://doi.org/10.1111/j.1526-4610.2009.01339.x
doi: 10.1111/j.1526-4610.2009.01339.x
Bigal ME, Lipton RB, Winner P et al (2007) Migraine in adolescents: association with socioeconomic status and family history. Neurology 69:16–25. https://doi.org/10.1212/01.wnl.0000265212.90735.64
doi: 10.1212/01.wnl.0000265212.90735.64
pubmed: 17606878
Atasoy HT, Unal AE, Atasoy N, Emre U, Sumer M (2005) Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache 45:25–31. https://doi.org/10.1111/j.1526-4610.2005.05006.x
doi: 10.1111/j.1526-4610.2005.05006.x
pubmed: 15663609
Guidetti V, Dosi C, Bruni O (2014) The relationship between sleep and headache in children: implications for treatment. Cephalalgia 34:767–776. https://doi.org/10.1177/0333102414541817
doi: 10.1177/0333102414541817
pubmed: 24973419
Dosi C, Figura M, Ferri R, Bruni O (2015) Sleep and headache. Semin Pediatr Neurol. 22:105–112. https://doi.org/10.1016/j.spen.2015.04.005
doi: 10.1016/j.spen.2015.04.005
pubmed: 26072340
Kinik ST, Alehan F, Erol I, Kanra AR (2010) Obesity and paediatric migraine. Cephalalgia 30:105–109. https://doi.org/10.1111/j.1468-2982.2009.01907.x
doi: 10.1111/j.1468-2982.2009.01907.x
pubmed: 19489878
Verrotti A, Di Fonzo A, Penta L, Agostinelli S, Parisi P (2014) Obesity and headache/migraine: the importance of weight reduction through lifestyle modifications. Biomed Res Int 2014:420858. https://doi.org/10.1155/2014/420858
doi: 10.1155/2014/420858
pubmed: 24800223
pmcid: 3996319
Lateef TM, Merikangas KR, He J et al (2009) Headache in a national sample of American children: prevalence and comorbidity. J Child Neurol 24:536–543. https://doi.org/10.1177/0883073808327831
doi: 10.1177/0883073808327831
pubmed: 19406755
pmcid: 2794247
Abu-Arafeh I, Razak S, Sivaraman B, Graham C (2010) Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol 52:1088–1097. https://doi.org/10.1111/j.1469-8749.2010.03793.x
doi: 10.1111/j.1469-8749.2010.03793.x
pubmed: 20875042
Ashina M (2019) The most important advances in headache research in 2018. Lancet Neurol 18:5–6. https://doi.org/10.1016/S1474-4422(18)30434-4
doi: 10.1016/S1474-4422(18)30434-4
pubmed: 30563683
Goadsby PJ (2021) Headache research in 2020: disrupting and improving practice. Lancet Neurol 20:7–8. https://doi.org/10.1016/S1474-4422(20)30457-9
doi: 10.1016/S1474-4422(20)30457-9
pubmed: 33340486
Ashina M, Terwindt GM, Al-Karagholi MA et al (2021) Migraine: Disease characterisation, biomarkers, and precision medicine. Lancet 397:1496–1504. https://doi.org/10.1016/S0140-6736(20)32162-0
doi: 10.1016/S0140-6736(20)32162-0
pubmed: 33773610
Ford I, Norrie J (2016) Pragmatic trials. N Engl J Med 375:454–463. https://doi.org/10.1056/NEJMra1510059
doi: 10.1056/NEJMra1510059
pubmed: 27518663
Schwedt TJ, Tassorelli C, Silberstein SD et al (2022) Guidelines of the International Headache Society for Clinic-Based Headache Registries. Cephalalgia 42:1099–1115. https://doi.org/10.1177/03331024221099035
doi: 10.1177/03331024221099035
pubmed: 35514209
pmcid: 10141527
GBD 2019 Universal Health Coverage Collaborators (2020) Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet 396(10258):1250–1284. https://doi.org/10.1016/S0140-6736(20)30750-9
doi: 10.1016/S0140-6736(20)30750-9
Chung PW, Lee MJ, Park JW et al (2019) Differences of Cluster Headache on the basis of sex in the Korean cluster Headache Registry. Headache 59:1722–1730. https://doi.org/10.1111/head.13637
doi: 10.1111/head.13637
pubmed: 31535372
Hornik CP, Gelfand AA, Szperka CL et al (2020) Development of a prospective real-World Data Clinical Registry of children and adolescents with Migraine. Headache 60:405–415. https://doi.org/10.1111/head.13714
doi: 10.1111/head.13714
pubmed: 31758549
Pearl TA, Dumkrieger G, Chong CD, Dodick DW, Schwedt TJ (2020) Sensory hypersensitivity symptoms in Migraine with vs without aura: results from the American Registry for Migraine Research. Headache 60:506–514. https://doi.org/10.1111/head.13745
doi: 10.1111/head.13745
pubmed: 31965576
Sipilä JOT, Ruuskanen JO, Rautava P, Kytö V (2020) Adult Migraine Hospital Admission Trends in Finland: a Nationwide Registry Study. J Clin Med 9:320. https://doi.org/10.3390/jcm9020320
doi: 10.3390/jcm9020320
pubmed: 31979328
pmcid: 7073942
Pearl TA, Dumkrieger G, Chong CD, Dodick DW, Schwedt TJ (2020) Impact of depression and anxiety symptoms on patient-reported outcomes in patients with migraine: results from the American Registry for Migraine Research (ARMR). Headache 60:1910–1919. https://doi.org/10.1111/head.13911
doi: 10.1111/head.13911
pubmed: 32749685
Ishii R, Schwedt TJ, Kim SK, Dumkrieger G, Chong CD, Dodick DW (2020) Effect of Migraine on Pregnancy Planning: Insights From the American Registry for Migraine Research. Mayo Clin Proc 95:2079–2089. https://doi.org/10.1016/j.mayocp.2020.06.053
doi: 10.1016/j.mayocp.2020.06.053
pubmed: 32948327
Delussi M, Gentile E, Coppola G et al (2020) Investigating the effects of COVID-19 Quarantine in Migraine: an observational cross-sectional study from the Italian National Headache Registry (RICe). Front Neurol 11:597881. https://doi.org/10.3389/fneur.2020.597881
doi: 10.3389/fneur.2020.597881
pubmed: 33240213
pmcid: 7683429
Trivedi M, Dumkrieger G, Chong CD, Dodick DW, Schwedt TJ (2021) Impact of abuse on migraine-related sensory hypersensitivity symptoms: results from the American Registry for Migraine Research. Headache 61:740–754. https://doi.org/10.1111/head.14100
doi: 10.1111/head.14100
pubmed: 33779989
Chung PW, Kim BS, Park JW et al (2021) Smoking history and clinical features of Cluster Headache: results from the Korean cluster Headache Registry. J Clin Neurol 17:229–235. https://doi.org/10.3988/jcn.2021.17.2.229
doi: 10.3988/jcn.2021.17.2.229
pubmed: 33835743
pmcid: 8053542
Belvís R, Irimia P, Pozo-Rosich P et al (2021) MAB-MIG: registry of the Spanish neurological society of erenumab for migraine prevention. J Headache Pain 22:74. https://doi.org/10.1186/s10194-021-01267-x
doi: 10.1186/s10194-021-01267-x
pubmed: 34273947
pmcid: 8285868
Park HK, Chu MK, Oh SY et al (2022) Interim analysis of the Registry for load and management of medication overuse headache (RELEASE): a multicenter, comprehensive medication overuse headache registry. Cephalalgia 42:455–465. https://doi.org/10.1177/03331024211057184
doi: 10.1177/03331024211057184
pubmed: 34786971
Leibovit-Reiben Z, Ishii R, Dodick DW et al (2022) The impact of pre-morbid headaches on headache features and long-term health outcomes following traumatic brain injury: insights from the American Registry for Migraine Research. Headache 62:566–576. https://doi.org/10.1111/head.14311
doi: 10.1111/head.14311
pubmed: 35593782
Ruscheweyh R, Klonowski T, Goßrau G (2022) The headache registry of the German migraine and Headache Society (DMKG): baseline data of the first 1,351 patients. J Headache Pain 23:74. https://doi.org/10.1186/s10194-022-01447-3
doi: 10.1186/s10194-022-01447-3
pubmed: 35773650
pmcid: 9248100
Barbanti P, Egeo G, Aurilia C et al (2022) The first report of the Italian Migraine Registry (I-GRAINE). Neurol Sci 43(9):5725–5728. https://doi.org/10.1007/s10072-022-06214-5
doi: 10.1007/s10072-022-06214-5
pubmed: 35802219
World Health Organization (2022) Optimizing brain health across the life course: WHO position paper. World Health Organization, Geneva
Owolabi MO, Leonardi M, Bassetti C et al (2022) The neurology revolution. Lancet Neurol 21:960–961. https://doi.org/10.1016/S1474-4422(22)00394-5
doi: 10.1016/S1474-4422(22)00394-5
pubmed: 36137553
The Lancet Neurology (2022) WHO launches its global action plan for brain health. Lancet Neurol 21:671. https://doi.org/10.1016/S1474-4422(22)00266-6
doi: 10.1016/S1474-4422(22)00266-6
pubmed: 35841894